Brevetti EPO No.3377176 2021.10.20
Brevetti EPO
(10) Registration Number and Date
2022000012 2022.01.12
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2022/000012 2017.02.21
(40) Publication Number and Date
SM /T/2022/000012 2022.01.12
(30) Priority Details
US 201662298555 P
2016.02.23
(51) IPC Classes
(71/73) Applicant
(IT) MORGANDANE SCIENTIFIC, LLC : 2012 Seadrift Drive, Corona Del Mar, CA 92625, US
(72) Inventor
(IT) PATEL, Maulik : 1209 Oak Grove AvenueUnit 101, Burlingame, CA 94010, US
(IT) SRINIVASAN, Sundar : 2012 Seadrift Drive, Corona Del Mar, CA 92625, US
(IT) CHOW, Christina : 325 23rd Ave E, SeattleWashington 98112, US
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) METODO PER TRATTARE PAZIENTI AI QUALI SONO COSOMMINISTRATI RIVAROXABAN E VERAPAMIL
(EN) METHOD OF TREATING PATIENTS COADMINISTERED RIVAROXABAN AND VERAPAMIL
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2022.03.21
Event NameDateStatus
Filing2017.02.21Filed
Brevetto EPO concesso2022.01.12Published
Ricevuta pagamento annualita 62022.07.29Payed
Ricevuta pagamento annualita 72023.02.27Payed
Ricevuta pagamento annualita 82024.02.29Payed